Diederick (Rick) E. Grobbee, MD, PhD,FESC, is a Professor of Clinical Epidemiology at the University Medical Center (UMC) Utrecht, the Netherlands, and Chief Scientific Officer at Julius Clinical, an Academic Contract Research Organization (www.juliusclinical.com). In addition he is the Director of the Center for Circulatory Health at the UMC Utrecht. He was elected fellow of the Dutch Royal Academy of Sciences, and holds the chair of its Medical Advisory Committee and Medical Section.
Rick Grobbee has been a (principal) investigator in many large-scale epidemiologic studies and randomized intervention trials relating to the prevention and treatment of cardiovascular disease. In addition he works on the principles and methods of treatment research and co-coordinates the IMI-GetReal consortium His experience covers the full range of study designs including trials, cohorts and case-control studies. He is listed in the top 100 global most influential biomedical researchers (Eur J Clin Invest 2013 Dec;43(12):1339-65). Rick Grobbee has been on the editorial boards of several journals and (inter)national scientific, search, and site-visit committees. Current journal roles include senior consulting editor of the European Heart Journal and editor-in-chief of the European Journal of Preventive Cardiology. He is president-elect of the European Association for Cardiovascular Prevention and Rehabilitation. To date, Prof. Grobbee has authored or co-authored over 1,200 scientific papers, chapters, and books, and has supervised more than 130 PhD fellows. His Hirsch index is 121.
Rick Grobbee received an MD at the University of Utrecht and, after a residency in internal medicine, obtained a PhD in Epidemiology at Erasmus University. In 1989 he was a Visiting Associate Professor of Epidemiology at Harvard School of Public Health. He was appointed full professor of Clinical Epidemiology at Erasmus University in 1993. Subsequently he moved to the University Medical Center Utrecht where he founded the Julius Center for Health Sciences and Primary Care in 1996 (www.juliuscenter.nl), which currently is one of the most productive clinical epidemiology groups in Europe with over 500 staff and fellows. Julius Clinical (www.juliusclinical.com) was established as a spin-off Academic Research Organization in 2008 and runs investigator-initiated and pharma-sponsored clinical trials in more than 30 countries involving over 120.000 patients. Rick Grobbee holds honorary appointments at the University of Malaya, Kuala Lumpur, Malaysia, and the University of Sydney, Australia. In 2010 he was appointed distinguished University Professor of International Health Sciences and Global Health at Utrecht University. In 2012 he initiated Elevate, a platform for accredited e-learning in international health sciences (www.elevatehealth.eu).